DaVita Financial Ratios
NYSE: DVAHealth CareMisc Health and Biotechnology ServicesUSD
179.25+2.23 (+1.26%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
DaVita ratio analysis
DaVita earned a net margin of 5.5% in FY 2025, down from 7.3% a year earlier. At the end of FY 2025, DVA traded at 11.6 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 11.6 to 58.7, with a median of 14.2. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
DaVita financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 11.64 | 14.24 | 14.12 | 12.76 | 12.78 | 18.61 | 14.25 | 58.70 | 20.82 | 14.97 |
| Price / sales | 0.62 | 1.01 | 0.78 | 0.60 | 1.03 | 1.22 | 1.01 | 0.81 | 1.25 | 1.21 |
| Price / book | — | 107.23 | 9.01 | 9.75 | 15.84 | 10.17 | 5.39 | 2.49 | 2.91 | 2.79 |
| Operating margin | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% | 14.7% | 14.4% | 13.4% | 16.7% | 19.0% |
| Net margin | 5.5% | 7.3% | 5.7% | 4.8% | 8.4% | 6.7% | 7.1% | 1.4% | 6.1% | 8.2% |
| Free cash flow margin | 9.6% | 11.4% | 12.3% | 8.3% | 11.1% | 11.3% | 11.5% | 6.9% | 9.3% | 10.7% |
| Return on equity (ROE) | — | 773.1% | 65.5% | 78.7% | 129.5% | 55.9% | 38.0% | 4.3% | 14.1% | 18.9% |
| Return on assets (ROA) | 4.3% | 5.4% | 4.1% | 3.3% | 5.7% | 4.6% | 4.7% | 0.8% | 3.5% | 4.7% |
| Debt / equity | — | 77.99 | 7.95 | 12.53 | 11.79 | 5.84 | 3.80 | 2.73 | 1.99 | 1.96 |
| Current ratio | 1.29 | 1.26 | 1.19 | 1.20 | 1.32 | 1.27 | 1.56 | 1.72 | 2.86 | 1.47 |
| Revenue growth | 6.5% | 5.6% | 4.6% | -0.1% | 0.6% | 1.4% | -0.1% | 4.9% | 1.6% | 7.3% |
| EPS growth | -8.3% | 44.6% | 26.8% | -34.3% | 41.0% | 19.7% | 472.8% | -73.5% | -19.1% | 243.2% |